EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Advancing Alzheimer's disease treatment: A literature review on senolytic intervention

Victor C Onuh iD

Journal of Alzheimer’s Disease · 2025

DOI: 10.1177/13872877251376540 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Alzheimer’s Disease, 2025. Verfasst von Victor C Onuh. Beteiligte Einrichtung: College of Natural Sciences and Social Sciences, Minerva University, San Francisco, CA, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Senotherapeutics, Cellular Senescence. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 77 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD) is a leading cause of dementia, currently affecting over 50 million people globally. Despite decades of research, therapeutic development has continued to face high failure rates due to an incomplete understanding of the underlying disease mechanisms. Current drugs like rivastigmine focus on managing cognitive symptoms since there is no known cure to halt the disease's progression. However, recent research has suggested that advanced biological age, particularly the accumulation of senescent cells, is the most significant risk factor for AD pathology, and targeting these aging mechanisms may prove more effective in altering the disease progression. Senescent cells accumulate with age, contributing to inflammatory states and neurodegenerative diseases such as AD. Senolytic drugs, such as dasatinib and quercetin (D + Q), have shown promise in animal models by clearing senescent cells, delaying aging-related decline, and improving AD-related outcomes. This literature review aims to provide a comprehensive overview of the therapeutic potential of senolytic interventions for AD by examining the mechanisms of cellular senescence based on evidence of its accumulation in the human brain, critically analyzing the preclinical and clinical trials involving senolytic compounds, and discussing the implications and limitations of this approach. The findings from recent studies indicate that senolytics may pave the way for effective AD treatments, though further clinical validation is needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseSenotherapeuticsCellular SenescenceHumansAnimalsAgingQuercetinDasatinib

Stichwörter der Autor:innen

Alzheimer's diseasecellular senescencedasatinibquercetinsenescence-associated secretory phenotypessenescent cellssenolytic intervention

Substanzen

SenotherapeuticsQuercetinDasatinib

Autor:innen und Institutionen

  • College of Natural Sciences and Social Sciences, Minerva University, San Francisco, CA, USA.

ORCID-Profile: Victor C Onuh

Zitieren

APA

Onuh, V. C. (2025). Advancing Alzheimer's disease treatment: A literature review on senolytic intervention. Journal of Alzheimer’s Disease. https://doi.org/10.1177/13872877251376540

Vancouver

Onuh VC. Advancing Alzheimer's disease treatment: A literature review on senolytic intervention. Journal of Alzheimer’s Disease. 2025. doi:10.1177/13872877251376540

BibTeX
@article{Onuh2025,
  author = {Onuh, Victor C},
  title = {Advancing Alzheimer's disease treatment: A literature review on senolytic intervention},
  journal = {Journal of Alzheimer’s Disease},
  year = {2025},
  doi = {10.1177/13872877251376540}
}
Kostenlos starten →